ArticleNature medicine2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor.
Matthew R Janes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
206 papers cite itlatest 60 shown
this papertrialcites it